Sarepta Therapeutics
SRPT
#5186
Rank
โ‚น161.85 B
Marketcap
โ‚น1,509
Share price
0.37%
Change (1 day)
-2.92%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

EPS for Sarepta Therapeutics (SRPT)

EPS in 2026 (TTM): -โ‚น222.98

According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -โ‚น247.02. In 2025 the company made an earnings per share (EPS) of -โ‚น781.44 a decrease over its 2024 EPS that were of โ‚น230.11.

EPS history for Sarepta Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น222.98-71.47%
2025-โ‚น781.44-439.59%
2024โ‚น230.11
2018-โ‚น509.06603.9%
2017-โ‚น72.32-85.9%
2016-โ‚น512.825.2%
2015-โ‚น487.4653.1%
2014-โ‚น318.40-0%
2013-โ‚น318.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Gilead Sciences
GILD
-โ‚น291.16 17.87%๐Ÿ‡บ๐Ÿ‡ธ USA
PTC Therapeutics
PTCT
-โ‚น123.04-50.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
-โ‚น142.76-42.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น1,861-853.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Insmed
INSM
-โ‚น264.86 7.22%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚น126.80-48.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNAM
-โ‚น392.60 58.94%๐Ÿ‡บ๐Ÿ‡ธ USA